News
-
Houses of asthma
Monday | Apr 16 2018AUSTRALIAN children are commonly exposed to damp housing and gas stove emissions, both of which are contributing to childhood asthma, according to new research published in the latest Medical Journal of Australia.
-
AHPRA consultation
Monday | Apr 16 2018THE Australian Health Practitioner Regulation Agency has published a consultation paper on a draft guideline for informing the Pharmacy Board about where pharmacists practice.
-
Digital health CRC
Monday | Apr 16 2018THE Federal Government has approved funding for a new Digital Health Cooperative Research Centre (DHCRC) promising to save the Australian health system $1.8b and create at least 1,000 new jobs in the digital health sector.
-
Dispensary Corner
Monday | Apr 16 2018
16 Apr 18VISITORS to Bull City Burger and Brewery in Durham, North Carolina in the USA are being offered a unique delicacy as part of an annual Exotic Meat Month.
-
Weekly Comment 16 Apr 18: Do you want a probiotic with that?
Monday | Apr 16 2018WELCOME to PD's weekly comment feature.
-
Events Calendar 13 Apr 18
Friday | Apr 13 201828-29 Apr: Victorian Pharmacy Conference 2018; Parkville, Victoria; find out more here: www.psa.org.au, 3-6 May: APP.
-
COAG cannabis proposal
Friday | Apr 13 2018FEDERAL Health Minister Greg Hunt will today propose to the Council of Australian Governments (COAG) new procedures that would facilitate patient access to medicinal cannabis across the country within 48 hours, assuming national responsibility for the approval process in lieu of state control.
-
PBS chemo ID mandatory
Friday | Apr 13 2018THE Health Department has reminded pharmacies that the inclusion of the Compounder ID field within a claim for PBS items under the Efficient Funding of Chemotherapy program became mandatory from 01 Dec 2017.
-
Cannabis Expo Sydney
Friday | Apr 13 2018AUSTRALIA'S largest cannabis event, the Hemp Health & Innovation (HHI) Expo & Symposium is heading back to Sydney 12 - 13 May.
-
Alexion to buy Wilson
Friday | Apr 13 2018RARE diseases specialist pharmaceutical company Alexion has announced it has made a public cash offer to the shareholders of Wilson Therapeutics, a research company with a copper toxicity disease focus, to acquire all outstanding shares in the company.
